ARG54921

anti-BACE1 antibody

anti-BACE1 antibody for ELISA,Western blot,ICC/IF and Human,Mouse

Cell Biology and Cellular Response antibody; Neuroscience antibody

Overview

Product Description Rabbit Polyclonal antibody recognizes BACE1
Tested Reactivity Hu, Ms
Tested Application ELISA, ICC/IF, WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name BACE1
Antigen Species Human
Immunogen Syntehtic peptide (17 aa) within the last 50 aa of Human BACE.
Conjugation Un-conjugated
Alternate Names Beta-site APP cleaving enzyme 1; BACE; Beta-secretase 1; Membrane-associated aspartic protease 2; HSPC104; Memapsin-2; ASP2; Asp 2; EC 3.4.23.46; Aspartyl protease 2; Beta-site amyloid precursor protein cleaving enzyme 1

Application Instructions

Application Suggestion
Tested Application Dilution
ELISAAssay-dependent
ICC/IF10 μg/ml
WB1 μg/ml
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
Positive Control Human Brain Tissue Lysate

Properties

Form Liquid
Purification Ion exchange chromatography purified.
Buffer PBS and 0.02% Sodium azide
Preservative 0.02% Sodium azide
Concentration 1 mg/ml
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 23621 Human BACE1

GeneID: 23821 Mouse BACE1

Swiss-port # P56817 Human Beta-secretase 1

Swiss-port # P56818 Mouse Beta-secretase 1

Gene Symbol BACE1
Gene Full Name beta-site APP-cleaving enzyme 1
Background BACE Antibody: Accumulation of the amyloid-beta (Abeta) plaque in the cerebral cortex is a critical event in the pathogenesis of Alzheimer's disease. Abeta peptide is generated by proteolytic cleavage of the beta-amyloid protein precursor (APP) at beta- and gamma-sites by two proteases. APP is first cleaved by beta-secretase, producing a soluble derivative of the protein and a membrane anchored 99-amino acid carboxy-terminal fragment (C99). The C99 fragment serves as substrate for gamma-secretase to generate the 4 kDa amyloid-beta peptide, which is deposited in the brains of all suffers of Alzheimer's disease. The long-sought beta-secretase was recently identified by several groups independently and designated beta-site APP cleaving enzyme (BACE) and aspartyl protease 2 (Asp2). BACE/Asp2 is a novel transmembrane aspartic protease and colocalizes with APP.
Function Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase. [UniProt]
Highlight Related products:
BACE1 antibodies; Anti-Rabbit IgG secondary antibodies;
Related news:
Beta-amyloid Peptide, the Dr Jekyll and Mr Hyde of Alzheimer’s Disease
Research Area Cell Biology and Cellular Response antibody; Neuroscience antibody
Calculated MW 56 kDa
PTM N-Glycosylated.
Acetylated in the endoplasmic reticulum at Lys-126, Lys-275, Lys-279, Lys-285, Lys-299, Lys-300 and Lys-307. Acetylation by NAT8 and NAT8B is transient and deacetylation probably occurs in the Golgi. Acetylation regulates the maturation, the transport to the plasma membrane, the stability and the expression of the protein.
Palmitoylation mediates lipid raft localization.